Novo Nordisk enters collaboration with University of Oxford on type 2 diabetes.
Novo Nordisk enters collaboration with University of Oxford on type 2 diabetes.
Our Chief Science Officer Mads Krogsgaard Thomsen shares his perspective on the collaboration with University of Oxford on Type 2 diabetes.
source
Comments